Related Articles
Expression of thymidylate synthase predicts clinical outcomes of S‑1‑based chemotherapy in squamous cell lung cancer
Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors
Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced non‑small cell lung cancer patients treated with pemetrexed‑based chemotherapy
Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1). Study Group of S-1 for Gastric Cancer.
Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy